—James J. Hsieh, MD, PhD, tells us how he thinks the kidney cancer treatment landscape will evolve in coming years. Median survival for patients with metastatic kidney cancer has doubled from 15 ...

A new study from the University of Michigan Health Rogel Cancer Center and the Department of Pathology has found a way to ...

The Division of Anatomic Pathology at the University of Alabama at Birmingham offers a one-year fellowship experience in Genitourinary (GU) and Renal pathology. The University of Alabama at Birmingham ...

Renal cell carcinoma (RCC) is not a single entity but includes various tumor subtypes that have been identified on the basis of either characteristic pathologic features or distinctive molecular ...

Kidney cancer has a wide range of presentations and spread, and each site of metastasis has varying prognostic significance, explained Daniel J. George, MD, professor of Medicine, member of the Duke ...

What is your research focus? We are interested in genetic programs in the tumor microenvironment that drive cancer progression. To date, this has largely hinged on genetically (using ...

A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing ...

What do you know about the pathologists analyzing your patients' specimens? Are you sure the person signing off on the report is qualified to do so? Some services can analyze and evaluate urologic ...

Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and ...

The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.